mci 9038 has been researched along with Ischemic Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, M; Chuck, C; Feler, J; Jayaraman, MV; McTaggart, R; Moldovan, K; Poggi, J; Sweeney, J; Torabi, R | 1 |
| Chen, HS; Cui, Y; Hou, XW; Li, XQ; Tian, XF; Wang, XH; Zhou, ZH | 1 |
| Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ | 1 |
| Chen, HS; Cui, Y; Dai, YJ; Duan, YJ; Feng, YF; Jiang, CH; Li, GH; Liu, XD; Ma, GB; Peng, ZL; Shen, L; Sun, YL; Wang, DL; Wang, EQ; Wang, FY; Wang, K; Wang, LH; Wang, RX; Wang, YL; Yang, HP; Yang, QC; Yuan, ZM; Zhang, Y; Zhao, LW; Zhou, ZH; Zou, RL | 1 |
| Wu, T; Xu, S; Xu, Z; Zhang, W; Zhang, Y | 1 |
| Liu, P; Liu, S; Lu, H; Ma, X; Wang, L; Wang, P; Wang, Y; Zhang, F | 1 |
| Kawashima, M; Michiwaki, Y; Samura, K; Suehiro, E; Tabei, Y; Tanaka, T; Wakamiya, T | 1 |
3 trial(s) available for mci 9038 and Ischemic Stroke
| Article | Year |
|---|---|
Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis.
Topics: Arginine; Arteries; Atherosclerosis; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Pipecolic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Sulfonamides; Treatment Outcome | 2022 |
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
Topics: Aged; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2023 |
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
Topics: Aged; Antithrombins; Arginine; Blood Flow Velocity; Brain Ischemia; Cerebral Veins; Drainage; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tissue Plasminogen Activator | 2020 |
4 other study(ies) available for mci 9038 and Ischemic Stroke
| Article | Year |
|---|---|
Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion.
Topics: Aspirin; Brain Ischemia; COVID-19; Humans; Ischemic Stroke; Middle Aged; Retrospective Studies; SARS-CoV-2; Stroke; Thrombectomy; Ticagrelor; Treatment Outcome | 2023 |
Development of a carotid artery thrombolysis stroke model in mice.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration.
Topics: Aspirin; Brain Ischemia; Humans; Ischemic Stroke; Prognosis; Stroke; Treatment Outcome | 2023 |
Emergent Carotid Artery Stenting Following Intravenous Alteplase Infusion After Rapid Negative Diagnosis for COVID-19 by Loop-Mediated Isothermal Amplification Assay.
Topics: Aged; Arginine; Carotid Stenosis; Combined Modality Therapy; COVID-19; Fibrinolytic Agents; Hemiplegia; Humans; Ischemic Stroke; Magnetic Resonance Imaging; Male; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2021 |